FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

467011000001109: Zyprexa 5mg tablets (Eli Lilly & Co Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16996501000001117 Zyprexa 5mg tablets (Eli Lilly & Co Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41147801000001113 Zyprexa 5mg tablets (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Is a Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has active ingredient Atypical antipsychotic false Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has active ingredient Olanzapine false Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Is a Zyprexa true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) 28 tablet 4 x 7 tablets Is pack of False Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Zyprexa 5mg tablets (Eli Lilly & Co Ltd) 28 tablet 4 x 7 tablets Has AMP True Zyprexa 5mg tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start